Delivery Order SPE2DB22D2206-SPE2DB25FFF16

Award Date 1/23/25
Potential Completion Date 2/13/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical products. The contract has a ceiling value of $16,017.54 and is a delivery order with a firm fixed price pricing type. The contract is for the delivery of BOSULIF 100 MG TABLET 120S, a prescription medication, with a completion date of May 13, 2024. Amerisourcebergen, as a major supplier of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,955.43 firm fixed-price delivery order is for the supply of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award, valued at $10,955.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 firm fixed-price delivery order is for the supply of BOSULIF 400 MG TABLET 30S, a specialty pharmaceutical product, with a performance period through December 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This contract award is for the pharmaceutical product Bosulif 400 mg Tablet 30s, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price delivery order has a ceiling value of $10,955.43 and an ultimate completion date of June 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 firm fixed-price delivery order contract is for the supply of BOSULIF 400 MG TABLET 30S, a prescription drug, with a period of performance through March 18, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $11,334.07 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the performance location is Conshohocken, PA. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $10,955.43, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product, with a completion date of June 11, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,910.86, is for the delivery of Bosulif 400 mg tablets. It is a firm fixed-price delivery order contract with a completion date of July 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,955.43 firm fixed price contract is for the delivery of BOSULIF 400 MG TABLET 30S, a prescription medication, with a completion date of November 6, 2024. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFF16
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of BOSULIF 100 MG TABLET 120S, a pharmaceutical product. The contract has a ceiling value of $11,047.42 and an ultimate completion date of February 13, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/24/25, 10:05 AM